BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 19055230)

  • 1. Design of floating bilayer tablets of diltiazem hydrochloride and lovastatin.
    Kulkarni AS; Bhatia MS
    PDA J Pharm Sci Technol; 2008; 62(5):344-52. PubMed ID: 19055230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug release kinetic analysis and prediction of release data via polymer molecular weight in sustained release diltiazem matrices.
    Adibkia K; Ghanbarzadeh S; Mohammadi G; Khiavi HZ; Sabzevari A; Barzegar-Jalali M
    Drug Res (Stuttg); 2014 Mar; 64(3):118-23. PubMed ID: 23986307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation development and evaluation of Diltiazem HCl sustained release matrix tablets using HPMC K4M and K100M.
    Qazi F; Shoaib MH; Yousuf RI; Qazi TM; Mehmood ZA; Hasan SM
    Pak J Pharm Sci; 2013 Jul; 26(4):653-63. PubMed ID: 23811439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies in release behavior of diltiazem HCl from matrix tablets containing (hydroxypropyl)methyl cellulose and xanthan gum.
    Gohel MC; Amin AF; Patel KV; Panchal MK
    Boll Chim Farm; 2002; 141(1):21-8. PubMed ID: 12064053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation, in vitro evaluation and study of variables on tri-layered gastro-retentive delivery system of diltiazem HCl.
    Raut Desai S; Rohera BD
    Drug Dev Ind Pharm; 2014 Mar; 40(3):380-9. PubMed ID: 23369093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing lyoequivalency for three commercially sustained-release tablets containing diltiazem hydrochloride.
    Maswadeh HA; Al-Hanbali OA; Kanaan RA; Shakya AK; Maraqa A
    Acta Pol Pharm; 2010; 67(1):93-7. PubMed ID: 20210085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
    Marinich JA; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of diltiazem hydrochloride diffusion-controlled transdermal delivery system.
    Limpongsa E; Umprayn K
    AAPS PharmSciTech; 2008; 9(2):464-70. PubMed ID: 18431661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and in-vitro evaluation of floating bilayer tablet of lisinopril maleate and metoprolol tartrate.
    Ijaz H; Qureshi J; Danish Z; Zaman M; Abdel-Daim M; Hanif M; Waheed I; Mohammad IS
    Pak J Pharm Sci; 2015 Nov; 28(6):2019-25. PubMed ID: 26639495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release profile comparison and stability of diltiazem-resin microcapsules in sustained release suspensions.
    Junyaprasert VB; Manwiwattanakul G
    Int J Pharm; 2008 Mar; 352(1-2):81-91. PubMed ID: 18061381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and evaluation of different floating tablets containing metronidazole to target stomach.
    Loh ZC; Elkordy AA
    Curr Drug Deliv; 2015; 12(4):425-43. PubMed ID: 25924732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and evaluation of gastroretentive controlled release tablets of alfuzosin hydrochloride.
    Rudraswamy-Math NR; Gupta VR
    Pak J Pharm Sci; 2015 Nov; 28(6):2147-52. PubMed ID: 26639508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and optimization of floating matrix tablets of clarithromycin using simplex lattice design.
    Singh I; Saini V
    Pak J Pharm Sci; 2016 Mar; 29(2):511-9. PubMed ID: 27087096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel use of similarity factors f2 and Sd for the development of diltiazem HCl modified-release tablets using a 3(2) factorial design.
    Gohel MC; Panchal MK
    Drug Dev Ind Pharm; 2002 Jan; 28(1):77-87. PubMed ID: 11858527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and in vivo floating behavior of verapamil HCl intragastric floating tablets.
    Patel A; Modasiya M; Shah D; Patel V
    AAPS PharmSciTech; 2009; 10(1):310-5. PubMed ID: 19296224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and in vitro evaluation of an oral floating matrix tablet formulation of diltiazem hydrochloride.
    Gambhire MN; Ambade KW; Kurmi SD; Kadam VJ; Jadhav KR
    AAPS PharmSciTech; 2007 Sep; 8(3):E73. PubMed ID: 17915823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of solvent on retarding the release of diltiazem HCl from Polyox-based liquisolid tablets.
    Kaialy W; Bello H; Asare-Addo K; Nokhodchi A
    J Pharm Pharmacol; 2016 Nov; 68(11):1396-1402. PubMed ID: 27714817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and evaluation of effervescent floating tablets of tizanidine hydrochloride.
    Someshwar K; Chithaluru K; Ramarao T; Kumar KK
    Acta Pharm; 2011 Jun; 61(2):217-26. PubMed ID: 21684848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divisability of diltiazem matrix sustained-release tablets.
    Costa P; Sousa Lobo JM
    Pharm Dev Technol; 2001 Aug; 6(3):343-51. PubMed ID: 11485176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theophylline loaded gastroretentive floating tablets based on hydrophilic polymers: preparation and in vitro evaluation.
    Khan F; Ibn Razzak SM; Khan ZR; Azad MA; Chowdhury JA; Reza S
    Pak J Pharm Sci; 2009 Apr; 22(2):155-61. PubMed ID: 19339225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.